Gibson Christopher 的 Form 4 申報
Recursion Pharmaceuticals, Inc.（RXRX），2022/3/15 申報
- 申報編號
- 0001209191-22-019019
- 申報時間
- 2022/3/15
- 交易日
- 2022/3/11-3/15
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 6 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $217.7 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Gibson ChristopherCIK 0001856369 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/3/11 | Class A Common Stock | C轉換取得 | +100,000 | $0.00F2 | $0 | 334,020 | 直接 | |
| 2022/3/11 | Class A Common Stock | S賣出處分 | −100,000 | $6.95F4 | −$695,000 | 234,020 | 直接 | |
| 2022/3/14 | Class A Common Stock | C轉換取得 | +230,000 | $0.00F2 | $0 | 464,020 | 直接 | |
| 2022/3/14 | Class A Common Stock | S賣出處分 | −230,000 | $6.28F5 | −$1,444,400 | 234,020 | 直接 | |
| 2022/3/15 | Class A Common Stock | C轉換取得 | +6,150 | $0.00F2 | $0 | 240,170 | 直接 | |
| 2022/3/15 | Class A Common Stock | S賣出處分 | −6,150 | $6.08F6 | −$37,392 | 234,020 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
表 I 有 3 筆、表 II 有 3 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $6.72 to $7.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $6.065 to $6.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $5.83 to $6.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price
表 I 有 1 筆交易的價格引用這則附註。